Sight Sciences Inc
NASDAQ:SGHT
| Market Cap (Intraday) | 254.21M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $5.42 |
| 50-Day MA | $4.84 |
| 200-Day MA | $4.80 |
Sight Sciences Inc Stock, NASDAQ:SGHT
4040 Campbell Avenue, Suite 100, Menlo Park, California 94025
United States of America
Phone: +1.877.266.1144
Number of Employees: 214
Description
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.